IL161445A0 - Stents - Google Patents

Stents

Info

Publication number
IL161445A0
IL161445A0 IL16144502A IL16144502A IL161445A0 IL 161445 A0 IL161445 A0 IL 161445A0 IL 16144502 A IL16144502 A IL 16144502A IL 16144502 A IL16144502 A IL 16144502A IL 161445 A0 IL161445 A0 IL 161445A0
Authority
IL
Israel
Prior art keywords
stents
Prior art date
Application number
IL16144502A
Other languages
English (en)
Original Assignee
Bayer Healthcase Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcase Ag filed Critical Bayer Healthcase Ag
Publication of IL161445A0 publication Critical patent/IL161445A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/04—Use of organic materials, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Surgery (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials Engineering (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL16144502A 2001-10-24 2002-02-11 Stents IL161445A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10152460A DE10152460A1 (de) 2001-10-24 2001-10-24 Stents
PCT/EP2002/011402 WO2003035133A1 (de) 2001-10-24 2002-10-11 Stents

Publications (1)

Publication Number Publication Date
IL161445A0 true IL161445A0 (en) 2004-09-27

Family

ID=7703557

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16144502A IL161445A0 (en) 2001-10-24 2002-02-11 Stents

Country Status (22)

Country Link
US (1) US20050064006A1 (de)
EP (1) EP1439869A1 (de)
JP (1) JP2005506151A (de)
KR (1) KR20040074977A (de)
CN (1) CN1575189A (de)
AU (1) AU2002340549B2 (de)
BR (1) BR0213481A (de)
CA (1) CA2464290A1 (de)
DE (1) DE10152460A1 (de)
EC (1) ECSP045075A (de)
EE (1) EE200400080A (de)
HR (1) HRP20040456A2 (de)
HU (1) HUP0401760A3 (de)
IL (1) IL161445A0 (de)
MA (1) MA26341A1 (de)
MX (1) MXPA04003755A (de)
NO (1) NO20041984L (de)
NZ (1) NZ532443A (de)
PL (1) PL367968A1 (de)
RU (1) RU2004115757A (de)
WO (1) WO2003035133A1 (de)
ZA (1) ZA200402989B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19962924A1 (de) * 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
DE10129725A1 (de) * 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
DE10300111A1 (de) * 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
EP1685841A1 (de) 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prophylaxe und Behandlung von thrombolischen Erkrankungen
DE102005045518A1 (de) * 2005-09-23 2007-03-29 Bayer Healthcare Ag 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
SG166126A1 (en) 2005-10-04 2010-11-29 Bayer Schering Pharma Ag Novel polymorphous form and the amorphous form of 5-chloro-n-({(5s)-2-oxo- 3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide
DE102005047561A1 (de) 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
DE102005047558A1 (de) * 2005-10-04 2008-02-07 Bayer Healthcare Ag Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen
US20070097252A1 (en) * 2005-10-31 2007-05-03 Silverstein D A Imaging methods, cameras, projectors, and articles of manufacture
DE102006034916A1 (de) * 2006-07-28 2008-01-31 Bayer Healthcare Ag Beschichtung künstlicher Oberflächen von medizinischen Hilfsmitteln und Geräten sowie Reinigung und/oder Vorbehandlung von Kathetern und anderen medizinischen Hilfsmitteln und Geräten
DE102006051625A1 (de) * 2006-11-02 2008-05-08 Bayer Materialscience Ag Kombinationstherapie substituierter Oxazolidinone
EP2220079A2 (de) 2007-11-15 2010-08-25 Boehringer Ingelheim International GmbH Substituierte amide sowie ihre herstellung und verwendung als medikamente
US11654036B2 (en) 2020-05-26 2023-05-23 Elixir Medical Corporation Anticoagulant compounds and methods and devices for their use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0623615T3 (da) * 1993-05-01 1999-12-13 Merck Patent Gmbh Adhæsionsreceptor-antagonister
US6133256A (en) * 1997-04-14 2000-10-17 Cor Therapeutics Inc Selective factor Xa inhibitors
US6273913B1 (en) * 1997-04-18 2001-08-14 Cordis Corporation Modified stent useful for delivery of drugs along stent strut
US20010029351A1 (en) * 1998-04-16 2001-10-11 Robert Falotico Drug combinations and delivery devices for the prevention and treatment of vascular disease
DE19962924A1 (de) * 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
DE10105989A1 (de) * 2001-02-09 2002-08-14 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung

Also Published As

Publication number Publication date
CA2464290A1 (en) 2003-05-01
CN1575189A (zh) 2005-02-02
HUP0401760A3 (en) 2008-04-28
HUP0401760A2 (hu) 2004-12-28
BR0213481A (pt) 2004-11-03
MA26341A1 (fr) 2004-10-01
NZ532443A (en) 2005-11-25
ECSP045075A (es) 2004-05-28
HRP20040456A2 (en) 2005-06-30
US20050064006A1 (en) 2005-03-24
EE200400080A (et) 2004-08-16
AU2002340549B2 (en) 2007-11-29
DE10152460A1 (de) 2003-05-08
KR20040074977A (ko) 2004-08-26
NO20041984L (no) 2004-05-13
WO2003035133A1 (de) 2003-05-01
EP1439869A1 (de) 2004-07-28
RU2004115757A (ru) 2005-04-10
MXPA04003755A (es) 2004-07-23
PL367968A1 (en) 2005-03-07
ZA200402989B (en) 2005-04-20
JP2005506151A (ja) 2005-03-03

Similar Documents

Publication Publication Date Title
EP1377233A4 (de) Monokanalikular-stent
DE50202400D1 (en) Baw-resonator
DE50201180D1 (en) Organopolysiloxan/polyharnstoff/polyurethan-blockcopolymere
GB2362107B (en) Covered stents
HK1071526A1 (en) Osteophilic implants
PL347924A1 (en) Stent
GB0124847D0 (en) Prosthesis
IL161445A0 (en) Stents
AU2002340549A1 (en) Stents
AU2002360430A8 (en) 14-methyl-epothilones
GB0127033D0 (en) Stent manufacture
AU2002354966A1 (en) Stents
DE50201028D1 (en) Diarylgelbpigmentpraeparationen
GB0119103D0 (en) Travelbib
AU2002313943A8 (en) Electromobile
GB0122965D0 (en) Stent
GB2393660B (en) Covered stents
AU2001100134A4 (en) Enviro-trap
GB0126635D0 (en) Stent assembly
CA93646S (en) Fauteuil
AU2479P (en) Crackerjack xTriticosecale
CA93647S (en) Fauteuil
CA93959S (en) Tilt-latch
CA92665S (en) Bedboard
CA91502S (en) Bedboard